For: | Yang N, He LY, Liu P, Li ZY, Yang YC, Ping F, Xu LL, Li W, Zhang HB, Li YX. Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials. World J Diabetes 2024; 15(5): 1011-1020 [PMID: 38766432 DOI: 10.4239/wjd.v15.i5.1011] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v15/i5/1011.htm |
Number | Citing Articles |
1 |
Ehsan Amini-Salehi, Maryam Hasanpour, Abdulhadi Alotaibi, Pegah Rashidian, Seyyed Mohammad Hashemi, Amir Nasrollahizadeh, Negin Letafatkar, Parsa Saberian, Reza Amani-Beni, Najmeh Shanbehzadeh. Global research trends on DPP-4 inhibitors and cardiovascular outcomes: a comprehensive bibliometric analysis. Annals of Medicine & Surgery 2025; 87(4): 2133 doi: 10.1097/MS9.0000000000003089
|
2 |
Laura Simon-Szabó, Beáta Lizák, Gábor Sturm, Anikó Somogyi, István Takács, Zsuzsanna Németh. Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies. International Journal of Molecular Sciences 2024; 25(16): 9113 doi: 10.3390/ijms25169113
|